Opportunity Information: Apply for PAR 18 737

The Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) funding opportunity (PAR 18-737) is an NIH discretionary grant mechanism designed to support large, highly integrated research centers that tackle major, difficult questions in neuroscience and mental health. The emphasis is on bold, high-risk and high-impact science that benefits from a center structure, meaning the work is expected to be more synergistic and interconnected than what could realistically be accomplished through typical single-investigator or standard multi-project awards. These Conte Centers are built around interdisciplinary teams that work across different levels of analysis, bringing together complementary perspectives and methods to accelerate progress in understanding brain function and mental illness.

The research scope spans two broad lanes: basic neuroscience and translational mental health research. For basic neuroscience, the goal is to push forward fundamental brain and behavior science by uncovering and dissecting underlying mechanisms that can ultimately lay the groundwork for understanding mental disorders. For translational efforts, the program encourages projects that bridge basic and clinical neuroscience, especially where integration is essential to make meaningful progress. A key focus area is severe mental illnesses, with an explicit interest in research programs that connect discoveries in neural circuits, genes, cells, and behavior to clinical phenomena in a coherent way. Another major priority is developmental psychopathology, particularly neurobehavioral mechanisms and trajectories that begin in childhood and adolescence, where early-life pathways may shape later mental health outcomes. In practice, this means the FOA is looking for center-level programs that can link developmental processes to risk, resilience, and the emergence of symptoms across time.

A defining feature of the Conte Centers program is the expectation of an extraordinary level of integration. The center should not read like a collection of loosely related projects; it should function as a coordinated scientific enterprise where individual components inform one another, share conceptual frameworks and tools, and collectively produce insights that would not emerge from the parts alone. The FOA also highlights the use of integrative, novel, and creative experimental approaches, signaling that applicants are encouraged to propose cutting-edge strategies, cross-disciplinary methods, and innovative study designs when they are well-justified by the scientific questions. The "Clinical Trial Optional" label indicates that clinical trials may be included if appropriate, but they are not required; the center can be entirely basic, entirely translational, or a strategically designed blend of both.

Beyond the science, the program is also meant to strengthen the research workforce. Conte Centers are expected to create meaningful interdisciplinary research experiences for students and postdoctoral researchers, leveraging the center environment to provide training and professional development that cuts across traditional departmental boundaries. This reflects the broader intent to cultivate researchers who are comfortable working at interfaces such as computational and experimental neuroscience, basic and clinical research, or molecular and systems-level approaches.

Eligibility is broad and includes many types of U.S.-based organizations: state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (as long as they are not institutions of higher education when applying under the nonprofit category); for-profit organizations other than small businesses; and small businesses. The FOA explicitly calls out additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, non-U.S. (foreign) institutions are not eligible to apply as applicant organizations, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed under NIH policy, meaning a U.S. applicant can include certain defined international elements when justified and compliant with the NIH Grants Policy Statement.

From the administrative details provided, this opportunity was created on 2018-04-02, with an original closing date listed as 2019-05-24. The award ceiling is noted as $2,000,000, indicating the program supports substantial, center-scale budgets consistent with multi-component, collaborative research enterprises. The CFDA number associated with the program is 93.242, and the sponsoring agency is the National Institutes of Health. Overall, this FOA is best understood as a center grant meant for teams that can convincingly demonstrate that their scientific aims require deep coordination, shared infrastructure or conceptual integration, and a scale of collaboration that goes beyond what standard grant mechanisms are designed to support.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2018-04-02.
  • Applicants must submit their applications by 2019-05-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $2,000,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 737

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs) - Silvio O. Conte Centers (P50 Clinical Trial Optional) (PAR 18-737)

What is the Silvio O. Conte Centers funding opportunity (PAR 18-737)?

It is an NIH discretionary grant opportunity that supports large, highly integrated research centers focused on major, difficult questions in basic neuroscience or translational mental health research. The mechanism is a P50 center grant, designed for coordinated, multi-component programs rather than individual, stand-alone projects.

What makes a Conte Center different from a typical multi-project or single-investigator grant?

The defining expectation is an extraordinary level of integration and synergy across the center. The work should function as a coordinated scientific enterprise where components share conceptual frameworks, tools, and approaches, and where the combined output is greater than what the individual parts could reasonably produce on their own.

What types of research does this opportunity support?

The scope spans two broad lanes: (1) basic neuroscience and (2) translational mental health research. Basic programs aim to advance fundamental science of brain and behavior mechanisms that can lay groundwork for understanding mental disorders. Translational programs are encouraged to bridge basic and clinical neuroscience where tight integration is essential.

Does the FOA prioritize any specific mental health topics?

Yes. It highlights severe mental illnesses as a key focus area, with interest in research that coherently connects neural circuits, genes, cells, and behavior to clinical phenomena. Another emphasized priority is developmental psychopathology, especially neurobehavioral mechanisms and trajectories beginning in childhood and adolescence.

What does “developmental psychopathology” mean in the context of this FOA?

In this opportunity, it refers to center-level research programs that link developmental processes to risk, resilience, and the emergence of symptoms over time, particularly starting in childhood and adolescence and shaping later mental health outcomes.

Is this opportunity only for translational or only for basic research?

No. A center can be entirely basic, entirely translational, or a strategically designed blend of both, as long as the overall program is justified as requiring a center structure and deep integration.

What does “Clinical Trial Optional” mean?

It means clinical trials may be included if appropriate, but they are not required. The center can propose clinical trial activities when they are scientifically justified, while purely basic or non-trial translational research is also allowable.

What kind of scientific approach does NIH appear to be looking for here?

The FOA emphasizes bold, high-risk, and high-impact science that benefits from a center structure. It also highlights integrative, novel, and creative experimental approaches, including cutting-edge strategies, cross-disciplinary methods, and innovative study designs when well-justified by the scientific questions.

How integrated does the center need to be?

The FOA indicates the center should not read like loosely related projects. Individual components are expected to inform one another, share tools or conceptual frameworks, and collectively accelerate progress in ways that would not emerge from the parts alone.

Does this program support interdisciplinary teams?

Yes. Conte Centers are built around interdisciplinary teams that work across different levels of analysis and combine complementary perspectives and methods to accelerate progress in understanding brain function and mental illness.

Does the FOA include workforce development or training expectations?

Yes. The program is also intended to strengthen the research workforce. Conte Centers are expected to create meaningful interdisciplinary research experiences for students and postdoctoral researchers, including training and professional development that crosses traditional departmental boundaries.

What kinds of trainee experiences are implied by the FOA?

The description emphasizes interdisciplinary experiences made possible by a center environment, such as training at interfaces like computational and experimental neuroscience, basic and clinical research, or molecular and systems-level approaches.

Who is eligible to apply?

Eligibility is broad for U.S.-based organizations, including: state/county/city/township/special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations not federally recognized; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (when not applying as an institution of higher education under the nonprofit category); for-profit organizations other than small businesses; and small businesses.

Are specific institution types explicitly called out as eligible?

Yes. The FOA explicitly mentions additional eligible applicant categories including HBCUs, Hispanic-serving institutions, TCCUs, Alaska Native and Native Hawaiian Serving Institutions, and AANAPISIs, as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.

Are non-U.S. (foreign) institutions eligible to apply as applicant organizations?

No. Non-U.S. (foreign) institutions are not eligible to apply as applicant organizations for this opportunity, based on the provided information.

Are non-domestic components of U.S. organizations eligible to apply?

No. Non-domestic components of U.S. organizations are also not eligible to apply, as stated in the opportunity summary provided.

Can a U.S. applicant include any foreign or international components?

Yes, foreign components are allowed under NIH policy. This means a U.S. applicant may include defined international elements when justified and when compliant with the NIH Grants Policy Statement.

What is the award ceiling for this opportunity?

The award ceiling is listed as $2,000,000, reflecting substantial, center-scale budgets consistent with multi-component collaborative research enterprises.

Who is the sponsoring agency?

The sponsoring agency is the National Institutes of Health (NIH).

What is the CFDA number associated with this opportunity?

The CFDA number listed for the program is 93.242.

When was this opportunity created and what is the listed closing date?

The opportunity was created on 2018-04-02, and the original closing date listed is 2019-05-24.

What scale of research program is this FOA aiming to support?

This FOA is intended for large, center-level programs that can demonstrate the need for deep coordination, shared infrastructure or conceptual integration, and collaboration at a scale beyond what standard grant mechanisms are designed to support.

Is the scientific focus limited to one level of analysis (for example, only genetics or only behavior)?

No. The program description emphasizes work across different levels of analysis and encourages connecting discoveries in neural circuits, genes, cells, and behavior to clinical phenomena in a coherent way, especially for severe mental illnesses and developmental trajectories.

What is the overall “fit” test implied by the FOA?

Based on the description provided, an ideal fit is a team with a bold, high-impact question in neuroscience or mental health that truly requires a center structure, with tightly linked components, shared methods or frameworks, and a plan that leverages interdisciplinary collaboration and training.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Early Psychosis Intervention Network (EPINET): Data Coordinating Center (U24 Clinical Trial Not Allowed)

Previous opportunity: NHLBI Clinical Ancillary Studies (R01 - Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 737

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 737) also looked into and applied for these:

Funding Opportunity
Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 011

Funding Number: RFA RM 18 011
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Limited Competition: Building Infrastructure Leading to Diversity (BUILD) Initiative Phase II (U54 Clinical Trial Not Allowed) Apply for RFA RM 18 006

Funding Number: RFA RM 18 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) Apply for RFA AR 19 007

Funding Number: RFA AR 19 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) Apply for RFA AR 19 006

Funding Number: RFA AR 19 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed) Apply for RFA AI 18 010

Funding Number: RFA AI 18 010
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,100,000
Making Health care Safer in Ambulatory Care Settings and Long Term Care Facilities (R18) Apply for PA 18 750

Funding Number: PA 18 750
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed) Apply for PAR 18 749

Funding Number: PAR 18 749
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional) Apply for PA 18 753

Funding Number: PA 18 753
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Next-Generation Biologics for Sustained HIV Remission (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 017

Funding Number: RFA AI 18 017
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed) Apply for PA 18 754

Funding Number: PA 18 754
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) Apply for PAR 18 755

Funding Number: PAR 18 755
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Curricular or Training Activities in Skills Development (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 759

Funding Number: PA 18 759
Agency: National Institutes of Health
Category: Health
Funding Amount: $80,000
Development of Curricular or Training Activities in Laboratory Safety (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 758

Funding Number: PA 18 758
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Curricular or Training Activities in Rigor and Transparency to Enhance Reproducibility (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 756

Funding Number: PA 18 756
Agency: National Institutes of Health
Category: Health
Funding Amount: $80,000
Administrative Supplements to NIGMS Predoctoral Training Grants for the Development of Activities to Prepare Trainees for Careers in the Biomedical Research Workforce (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 757

Funding Number: PA 18 757
Agency: National Institutes of Health
Category: Health
Funding Amount: $80,000
Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed) Apply for RFA HG 18 001

Funding Number: RFA HG 18 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $700,000
Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed) Apply for RFA HG 18 003

Funding Number: RFA HG 18 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed) Apply for RFA HG 18 002

Funding Number: RFA HG 18 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed) Apply for PAR 18 760

Funding Number: PAR 18 760
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) Apply for PAR 18 761

Funding Number: PAR 18 761
Agency: National Institutes of Health
Category: Health
Funding Amount: $499,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 737", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: